December 18, 2001
GENELABS TECHNOLOGIES PRESENTS ANTIBIOTIC RESEARCH AT THE 41st ANNUAL ICAAC CONFERENCE

December 17, 2001
GENELABS TECHNOLOGIES PRESENTS ANTIFUNGAL RESEARCH AT THE 41st ANNUAL ICAAC CONFERENCE

November 13, 2001
GENELABS TECHNOLOGIES, INC. REPORTS THIRD QUARTER AND NINE MONTH 2001 FINANCIAL RESULTS

October 16, 2001
GENELABS ANNOUNCES EXECUTIVE APPOINTMENTS

September 25, 2001
GENELABS TECHNOLOGIES ANNOUNCES PHASE II TRIAL FOR HEPATITIS E VIRUS VACCINE

September 6, 2001
GENELABS TECHNOLOGIES ENCOURAGED BY REPORTS IN NEW ENGLAND JOURNAL OF MEDICINE SHOWING INCREASED SURVIVAL WHEN PEOPLE WITH HIV ARE COINFECTED WITH HGV

August 30, 2001
GENELABS TECHNOLOGIES SCIENTISTS TO PRESENT AT INTERNATIONAL INFECTIOUS DISEASE MEETING

August 13, 2001
GENELABS TECHNOLOGIES, INC. REPORTS SECOND QUARTER AND SIX MONTH 2001 FINANCIAL RESULTS

June 26, 2001
FDA NOTIFIES GENELABS THAT ASLERA™ NDA IS NOT APPROVABLE

May 14, 2001
GENELABS TECHNOLOGIES, INC. REPORTS 2001 FIRST QUARTER FINANCIAL RESULTS

April 19, 2001
GENELABS AND WATSON REPORT ON FDA ADVISORY COMMITTEE MEETING FOR ASLERA™ NEW DRUG APPLICATION FOR LUPUS

March 29, 2001
GENELABS TECHNOLOGIES, INC. REPORTS 2000 YEAR END AND FOURTH QUARTER FINANCIAL RESULTS

March 28, 2001
GENELABS TECHNOLOGIES, INC. PRESENTS ANTIFUNGAL DATA AT INTERNATIONAL DRUG DISCOVERY CONFERENCE

February 20, 2001
ASLERA™ NEW DRUG APPLICATION TO BE REVIEWED AT FDA ADVISORY COMMITTEE MEETING ON APRIL 19, 2001

February 6, 2001
GENELABS TO PRESENT AT WALL STREET ANALYST FORUM

January 24, 2001
GENELABS APPOINTS CHAIRMAN IRENE A. CHOW, PH.D. AS CHIEF EXECUTIVE OFFICER

January 12, 2001
WATSON UPDATES INVESTORS ON LUPUS DRUG CANDIDATE

© Genelabs Technologies, Inc. All rights reserved. - Terms of Use